NCT07022106 Comparison of Different Physiotherapy Techniques in Dysmenorrhea
| NCT ID | NCT07022106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Dysmenorrhea Primary |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-06-15 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is investigating the effects of myofascial release technique \& kinesiotape in managing dysmenorrhea
Eligibility Criteria
Inclusion Criteria: * Diagnosis of primary dysmenorrhea, * Moderate-to-severe pain during menstrual days 1-3, * Regular menstrual cycles for past 6 months Exclusion Criteria: * Secondary gynaecological conditions, * Current use of pain medications, * History of pregnancy
Contact & Investigator
Gizem Ergezen Şahin, PhD
STUDY CHAIR
Medipol University
Frequently Asked Questions
Who can join the NCT07022106 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 30 Years, studying Dysmenorrhea Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07022106 currently recruiting?
Yes, NCT07022106 is actively recruiting participants. Contact the research team at salma.abdelzaher@std.medipol.edu.tr for enrollment information.
Where is the NCT07022106 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07022106 clinical trial?
NCT07022106 is sponsored by Medipol University. The principal investigator is Gizem Ergezen Şahin, PhD at Medipol University. The trial plans to enroll 46 participants.